Loomis Sayles & CO L P Rocket Pharmaceuticals, Inc. Transaction History

Loomis Sayles & CO L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $24.7 Million - $44 Million	-899,510 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $717,813 - $860,611	-18,214 Reduced 1.98%	899,510 $39.8 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $126,639 - $192,589	-2,922 Reduced 0.32%	917,724 $40.7 Million
Q4 2020 Feb 12, 2021	SELL	$23.3 - $59.57 $3.64 Million - $9.3 Million	-156,130 Reduced 14.5%	920,646 $50.5 Million
Q3 2020 Nov 12, 2020	BUY	$20.5 - $28.59 $2.28 Million - $3.18 Million	111,192 Added 11.52%	1,076,776 $24.6 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $12.9 Million - $21.8 Million	965,584 New	965,584 $20.2 Million

194

91.9M

222K

111K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.4B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.